Nomination committee appointed

As per specifications set at Meda’s 2014 annual general meeting, a nomination
committee has been appointed. It consists of:

Bert Åke Eriksson, Committee Chairman, Stena Sessan Rederi AB

Sigieri Diaz Pallavicini, Fidim S.r.l.

Evert Carlsson, Swedbank Robur Funds

Lars Backsell, B&E Participation/Flerie Invest

Martin Svalstedt, Meda’s Chairman of the Board

For further inquiries, please contact:

Paula Treutiger, Head of Corporate Communications and
IR                                           ph: +46 733-666 599


                                  paula.treutiger@meda.se

MEDA AB (publ) is a leading international specialty pharma company. Meda’s
products are sold in more than 120 countries worldwide and the company is
represented by its own organizations in close to 60 countries. The Meda share is
listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.